Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant Pain
Clinical trial NCT00225797 · COMPLETED
Trial details
- NCT number
- NCT00225797
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-11-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.